SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-19-003077
Filing Date
2019-12-27
Accepted
2019-12-26 17:56:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07422010_12262019.htm SC 13D 231412
2 JOINT FILING AGREEMENT ex991to13d07422010_12262019.htm EX-99.1 16739
  Complete submission text file 0000921895-19-003077.txt   249838
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87623 | Film No.: 191311257
SIC: 2834 Pharmaceutical Preparations